Search

everythinglearnresearchcommunity

for

Search:↓

Targeting specific T cells may help treat alopecia areata.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Too much zinc can cause hair loss and weaken the immune system.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Belatacept may be a promising treatment for alopecia areata.

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.

Upadacitinib improved multiple immune-related conditions in one patient.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Special cells can help regrow hair in alopecia areata.

Restoring nerve-macrophage communication may help treat autoimmune diseases.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

The treatment using a special hydrogel shows promise for promoting hair growth.

Urban air pollution worsens hair loss in alopecia areata by increasing immune response.

Arctium lappa L. might help treat immune-related skin diseases, but more research is needed.

Squaric acid dibutylester promotes hair growth by activating immune cells, especially macrophages.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Immune system changes may contribute to female pattern hair loss.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Immune cells and cytokines significantly affect pathological scar development.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.